News
An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, Johns Hopkins ...
A nationwide study found that TB history did not elevate long-term cancer risk among individuals living with HIV.
An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, Johns Hopkins ...
An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, Johns Hopkins ...
DURING SCREENING SEASON, which runs from March to December, LUCAS sets off on Mondays from the cancer institute in Morgantown ...
Lobectomy is a type of lung surgery to treat lung cancer or another lung disease. Learn its indications, types, potential risks, and what to expect during recovery.
UC San Diego study of global lung cancer shows mutations that lead to cancer are common in people who live in cities with bad air pollution. But cancer mutations are quite close to normal among ...
Tuberculosis may be a common misdiagnosis of lung cancer due to shared symptoms, although the condition is uncommon in the United States. Some lung conditions may also co-occur.
Experimental cancer drug could streamline standard tuberculosis treatment and prevent post-TB lung disease, study suggests. ScienceDaily . Retrieved June 11, 2025 from www.sciencedaily.com ...
In a Johns Hopkins Children’s Center study, the addition of navitoclax to the standard TB treatment significantly increased apoptosis (shown in red) in several lung cell populations including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results